Table 3 Summary of demographic and laboratory of patients with mifepristone-induced liver injury
Patient characteristics | Patient in this case report | Ref Funke [5] | Ref Shah [6] |
|---|---|---|---|
Age | 63 | 65 | 35 |
Gender | Female | Female | Female |
Ethnicity | Caucasian | Caucasian | Not available |
Time to onset (days) | 90 | 90 | 90 |
Peak bilirubin (mg/dL) | 28.3 | 33 | 21.4 |
Peak alkaline phosphatase (U/L) | 299 | 188 | 258 |
Peak ALT (U/L) | 231 | 169 | 68 |
Peak AST (U/L) | 189 | 53 | 56 |
Presentation to peak bilirubin (weeks) | 3 | 8 | Not available |
Presentation to peak alkaline phosphatase (weeks) | 8 | 8 | Not available |
Presentation to peak ALT (weeks) | 8 | 8 | Not available |
Peak INR | 1.2 | 1.44 | “within normal limits” |
R factor | 2.3 | 2.7 | 1.6 |
Time from peak to resolution (weeks) | 40 | 40 |